Amit Etkin's most recent trade in Alto Neuroscience Inc. was a trade of 215,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alto Neuroscience Inc. | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 215,000 | 215,000 | - | - | Employee Stock Option (Right to Buy) | |
Alto Neuroscience Inc. | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 223,000 | 223,000 | - | - | Employee Stock Option (Right to Buy) | |
Alto Neuroscience Inc. | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 34,711 | 1,240,176 | - | 0 | Common Stock | |
Alto Neuroscience Inc. | Amit Etkin | Director, PRESIDENT AND CEO | 06 Feb 2024 | 25,000 | 0 | - | - | Series B Preferred Stock | ||
Alto Neuroscience Inc. | Amit Etkin | Director, PRESIDENT AND CEO | 06 Feb 2024 | 11,777 | 1,202,340 | - | - | Common Stock | ||
Alto Neuroscience Inc. | Amit Etkin | Director, PRESIDENT AND CEO | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Feb 2024 | 3,125 | 1,205,465 | - | 16 | 50,000 | Common Stock |